Related references
Note: Only part of the references are listed.Regional Alterations of Brain Microstructure in Parkinson's Disease Using Diffusion Tensor Imaging
Wang Zhan et al.
MOVEMENT DISORDERS (2012)
DJ-1 and αSYN in LRRK2 CSF do not correlate with striatal dopaminergic function
Min Shi et al.
NEUROBIOLOGY OF AGING (2012)
[18F]FDOPA uptake in the raphe nuclei complex reflects serotonin transporter availability. A combined [18F]FDOPA and [11C]DASB PET study in Parkinson's disease
N. Pavese et al.
NEUROIMAGE (2012)
Cerebrospinal fluid amyloid β and tau in LRRK2 mutation carriers
J. O. Aasly et al.
NEUROLOGY (2012)
Plasma Epidermal Growth Factor Levels Predict Cognitive Decline in Parkinson Disease
Alice S. Chen-Plotkin et al.
ANNALS OF NEUROLOGY (2011)
White and Gray Matter Abnormalities in Idiopathic Rapid Eye Movement Sleep Behavior Disorder: A Diffusion-Tensor Imaging and Voxel-Based Morphometry Study
Christoph Scherfler et al.
ANNALS OF NEUROLOGY (2011)
Cerebrospinal Fluid Biomarkers for Parkinson Disease Diagnosis and Progression
Min Shi et al.
ANNALS OF NEUROLOGY (2011)
Age-Specific Progression of Nigrostriatal Dysfunction in Parkinson's Disease
Raul de la Fuente-Fernandez et al.
ANNALS OF NEUROLOGY (2011)
Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson's disease
Ramachandiran Nandhagopal et al.
BRAIN (2011)
Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Combined with Magnetic Beads for Detecting Serum Protein Biomarkers in Parkinson's Disease
Yao-Hua Li et al.
EUROPEAN NEUROLOGY (2011)
Advances in imaging in Parkinson's disease
A. Jon Stoessl et al.
LANCET NEUROLOGY (2011)
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study (vol 10, pg 230, 2011)
B. Mollenhauer et al.
LANCET NEUROLOGY (2011)
Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study
Alex Iranzo et al.
LANCET NEUROLOGY (2011)
A Within-Subject Comparison of 6-[18F]Fluoro-m-tyrosine and 6-[18F]Fluoro-L-dopa in Parkinson's Disease
Catherine L. Gallagher et al.
MOVEMENT DISORDERS (2011)
Serum Urate and Probability of Dopaminergic Deficit in Early Parkinson's Disease
Michael A. Schwarzschild et al.
MOVEMENT DISORDERS (2011)
Cerebrospinal Fluid Tau/α-Synuclein Ratio in Parkinson's Disease and Degenerative Dementias
Lucilla Parnetti et al.
MOVEMENT DISORDERS (2011)
High cerebrospinal tau levels are associated with the rs242557 tau gene variant and low cerebrospinal β-amyloid in Parkinson disease
Yaroslau Compta et al.
NEUROSCIENCE LETTERS (2011)
The Parkinson Progression Marker Initiative (PPMI)
Kenneth Marek et al.
PROGRESS IN NEUROBIOLOGY (2011)
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
Brit Mollenhauer et al.
LANCET NEUROLOGY (2011)
Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature
Patrice Peran et al.
BRAIN (2010)
DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease
Zhen Hong et al.
BRAIN (2010)
Degenerative parkinsonism in patients with psychogenic parkinsonism: A dopamine transporter imaging study
Andre C. Felicio et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2010)
Parkinson's disease spatial covariance pattern: noninvasive quantification with perfusion MRI
Yilong Ma et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2010)
Pilot study: peripheral biomarkers for diagnosing sporadic Parkinson's disease
Edna Gruenblatt et al.
JOURNAL OF NEURAL TRANSMISSION (2010)
Abnormalities in Metabolic Network Activity Precede the Onset of Motor Symptoms in Parkinson's Disease
Chris C. Tang et al.
JOURNAL OF NEUROSCIENCE (2010)
Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis
Chris C. Tang et al.
LANCET NEUROLOGY (2010)
Distinguishing SWEDDs Patients with Asymmetric Resting Tremor from Parkinson's Disease: A Clinical and Electrophysiological Study
Petra Schwingenschuh et al.
MOVEMENT DISORDERS (2010)
CSF Aβ42 and tau in Parkinson's Disease with Cognitive Impairment
Thomas J. Montine et al.
MOVEMENT DISORDERS (2010)
Dopamine Turnover Increases in Asymptomatic LRRK2 Mutations Carriers
Vesna Sossi et al.
MOVEMENT DISORDERS (2010)
Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease
T. Tokuda et al.
NEUROLOGY (2010)
Proteome analysis of the sera from Chinese Parkinson's disease patients
Xin Zhao et al.
NEUROSCIENCE LETTERS (2010)
Diffusion Tensor Imaging in Idiopathic REM Sleep Behavior Disorder Reveals Microstructural Changes in the Brainstem, Substantia Nigra, Olfactory Region, and Other Brain Regions
Marcus M. Unger et al.
SLEEP (2010)
Circulating interleukin-10 and interleukin-12 in Parkinson's disease
M. Rentzos et al.
ACTA NEUROLOGICA SCANDINAVICA (2009)
Urate as a Predictor of the Rate of Clinical Decline in Parkinson Disease
Alberto Ascherio et al.
ARCHIVES OF NEUROLOGY (2009)
Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study
R. Nandhagopal et al.
BRAIN (2009)
Olfaction in patients with suspected parkinsonism and scans without evidence of dopaminergic deficit (SWEDDs)
L. Silveira-Moriyama et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Proteomics in human Parkinson's disease research
Virginie Licker et al.
JOURNAL OF PROTEOMICS (2009)
A Follow-Up Study on 6-[18F]Fluoro-L-dopa Uptake in Early Parkinson's Disease Shows Nonlinear Progression in the Putamen
Anna Bruck et al.
MOVEMENT DISORDERS (2009)
Midbrain Hyperechogenicity in Idiopathic REM Sleep Behavior Disorder
Heike Stockner et al.
MOVEMENT DISORDERS (2009)
Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder
R. B. Postuma et al.
NEUROLOGY (2009)
Safety and tolerability of putaminal AADC gene therapy for Parkinson disease
C. W. Christine et al.
NEUROLOGY (2009)
High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease
D. E. Vaillancourt et al.
NEUROLOGY (2009)
A Cross-Study Transcriptional Analysis of Parkinson's Disease
Greg T. Sutherland et al.
PLOS ONE (2009)
Metabolomic Profiling in LRRK2-Related Parkinson's Disease
Krisztina K. Johansen et al.
PLOS ONE (2009)
Functional imaging studies of non-motoric manifestations of Parkinson's Disease
A. Jon Stoessl
PARKINSONISM & RELATED DISORDERS (2009)
Visualizing Vesicular Dopamine Dynamics in Parkinson's Disease
Raul de la Fuente-Fernandez et al.
SYNAPSE (2009)
Metabolic profiling of Parkinson's disease: evidence of biomarker from gene expression analysis and rapid neural network detection
Shiek S. S. J. Ahmed et al.
JOURNAL OF BIOMEDICAL SCIENCE (2009)
CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases
Jing Zhang et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Serum urate as a predictor of clinical and radiographic progression in Parkinson disease
Michael A. Schwarzschild et al.
ARCHIVES OF NEUROLOGY (2008)
Metabolomic profiling to develop blood biomarkers for Parkinson's disease
Mikhail Bogdanov et al.
BRAIN (2008)
Parkinson patient fibroblasts show increased alpha-synuclein expression
Hans-Hermann Hoepken et al.
EXPERIMENTAL NEUROLOGY (2008)
Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: Is VMAT2 a stable dopamine neuron biomarker?
Isabelle Boileau et al.
JOURNAL OF NEUROSCIENCE (2008)
Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform
Sheng Pan et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Uric acid in Parkinson's disease
Ilana Schlesinger et al.
MOVEMENT DISORDERS (2008)
Progression of dopaminergic dysfunction in a LRRK2 kindred A multitracer PET study
R. Nandhagopal et al.
NEUROLOGY (2008)
Midbrain iron content in early Parkinson disease - A potential biomarker of disease status
W. R. Wayne Martin et al.
NEUROLOGY (2008)
Dopamine modulating drugs influence striatal (+)-[11C]DTBZ binding in rats:: VMAT2 binding is sensitive to changes in vesicular dopamine concentration
Junchao Tong et al.
SYNAPSE (2008)
Peripheral inflammatory biomarkers and risk of Parkinson's disease
Honglei Chen et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease
Andrew Feigin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Patients with adult-onset dystonic tremor resembling parkinsonian tremor have scans without evidence of Dopaminergic deficit (SWEDDs)
Susanne A. Schneider et al.
MOVEMENT DISORDERS (2007)
Assessment of the progression of Parkinson's disease: a metabolic network approach
Thomas Eckert et al.
LANCET NEUROLOGY (2007)
Plasma urate and risk of Parkinson's disease
M. G. Weisskopf et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Changes in network activity with the progression of Parkinson's disease
Chaorui Huang et al.
BRAIN (2007)
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial
Michael G. Kaplitt et al.
LANCET (2007)
Increase of oxidized/total coenzyme Q-10 ratio in cerebrospinal fluid in patients with Parkinson's disease
Chiaki Isobe et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2007)
Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility
Yilong Ma et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
[123I]epidepride binding to cerebellar dopamine D2/D3 receptors is displaceable:: Implications for the use of cerebellum as a reference region
Lars H. Pinborg et al.
NEUROIMAGE (2007)
Quantification of Parkinson's disease-related network expression with ECD SPECT
Thomas Eckert et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Peripheral blood markers of oxidative stress in Parkinson's disease
S. Younes-Mhenni et al.
EUROPEAN NEUROLOGY (2007)
Successful antiparkinsonian medication withdrawal in patients with parkinsonism and normal FP-CIT SPECT
Vicky L. Marshall et al.
MOVEMENT DISORDERS (2006)
Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging
Vicky L. Marshall et al.
NUCLEAR MEDICINE COMMUNICATIONS (2006)
Network modulation in the treatment of Parkinson's disease
Kotaro Asanuma et al.
BRAIN (2006)
Proteomic identification of a stress protein, mortalin/mthsp70/GRP75 - Relevance to Parkinson disease
Jinghua Jin et al.
MOLECULAR & CELLULAR PROTEOMICS (2006)
Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease
Maja Trost et al.
NEUROIMAGE (2006)
Psychogenic parkinsonism:: A combination of clinical, electrophysiological, and [123I]-FP-CIT SPECT scan explorations improves diagnostic accuracy
S Benaderette et al.
MOVEMENT DISORDERS (2006)
Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease
AE Lang et al.
ANNALS OF NEUROLOGY (2006)
Detection of oligomeric forms of α-synuclein protein in human plasma as a potential biomarker for Parkinson's disease
Omar M. A. El-Agnaf et al.
FASEB JOURNAL (2006)
Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease
Nicolaas I. Bohnen et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2006)
PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation
JR Adams et al.
BRAIN (2005)
FDG PET in the differential diagnosis of parkinsonian disorders
T Eckert et al.
NEUROIMAGE (2005)
Urinary 8-hydroxydeoxyguanosine levels as a biomarker for progression of Parkinson disease
S Sato et al.
NEUROLOGY (2005)
Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease
D Berg et al.
MOVEMENT DISORDERS (2005)
Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity
R Hilker et al.
ARCHIVES OF NEUROLOGY (2005)
The role of radiotracer imaging in Parkinson disease
B Ravina et al.
NEUROLOGY (2005)
Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation
NL Khan et al.
NEUROLOGY (2005)
Metabolomics by numbers: acquiring and understanding global metabolite data
R Goodacre et al.
TRENDS IN BIOTECHNOLOGY (2004)
Redox status of plasma coenzyme Q10 indicates elevated systemic oxidative stress in Parkinson's disease
M Sohmiya et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2004)
Idiopathic hyposmia as a preclinical sign of Parkinson's disease
MM Ponsen et al.
ANNALS OF NEUROLOGY (2004)
Role of dopaminergic treatment in dopamine receptor down-regulation in advanced Parkinson disease - A positron emission tomographic study
S Thobois et al.
ARCHIVES OF NEUROLOGY (2004)
Detection of presymptomatic Parkinson's disease: Combining smell tests, transcranial sonography, and SPECT
U Sommer et al.
MOVEMENT DISORDERS (2004)
A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease
CW Olanow et al.
ANNALS OF NEUROLOGY (2003)
Monoamine neuron innervation of the normal human brain:: an 18F-DOPA PET study
RY Moore et al.
BRAIN RESEARCH (2003)
Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study
AL Whone et al.
ANNALS OF NEUROLOGY (2003)
VMAT2 binding is elevated in dopa-responsive dystonia:: Visualizing empty vesicles by PET
R De la Fuente-Fernández et al.
SYNAPSE (2003)
Progression of dopaminergic hypofunction in striatal subregions in Parkinson's disease using [18F]CFT PET
E Nurmi et al.
SYNAPSE (2003)
Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease
SS Gill et al.
NATURE MEDICINE (2003)
Correlation of dopamine transporter imaging with parkinsonian motor handicap: How close is it?
W Pirker
MOVEMENT DISORDERS (2003)
Apoptosis in Parkinson's disease: Signals for neuronal degradation
WG Tatton et al.
ANNALS OF NEUROLOGY (2003)
Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism:: An 18F-dopa PET study
NL Khan et al.
ANNALS OF NEUROLOGY (2002)
Protein misfolding, amyloid formation, and neurodegeneration: A critical role for molecular chaperones?
PJ Muchowskil
NEURON (2002)
Echogenicity of the substantia nigra -: Association with increased iron content and marker for susceptibility to nigrostriatal injury
D Berg et al.
ARCHIVES OF NEUROLOGY (2002)
Increase in dopamine turnover occurs early in Parkinson's disease:: Evidence from a new modeling approach to PET 18F-fluorodopa data
V Sossi et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2002)
Blinded positron emission tomography study of dopamine cell implantation for Parkinson's disease
T Nakamura et al.
ANNALS OF NEUROLOGY (2001)
Transplantation of embryonic dopamine neurons for severe Parkinson's disease.
CR Freed et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Decreased striatal dopaminergic innervation in REM sleep behavior disorder
RL Albin et al.
NEUROLOGY (2000)
Reproducibility and effect of levodopa on dopamine transporter function measurements:: A [18F]CFT PET study
E Nurmi et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2000)
Share Paper
